Your browser doesn't support javascript.
loading
Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.
Povsic, Thomas J; Scott, Rob; Mahaffey, Kenneth W; Blaustein, Robert; Edelberg, Jay M; Lefkowitz, Martin P; Solomon, Scott D; Fox, Jonathan C; Healy, Kevin E; Khakoo, Aarif Y; Losordo, Douglas W; Malik, Fady I; Monia, Brett P; Montgomery, Rusty L; Riesmeyer, Jeffrey; Schwartz, Gregory G; Zelenkofske, Steven L; Wu, Joseph C; Wasserman, Scott M; Roe, Matthew T.
Afiliação
  • Povsic TJ; Duke Clinical Research Institute, Duke University School of Medicine, 2400 Pratt Street, Duke Medicine, Durham, NC, 27705, USA. povsi001@mc.duke.edu.
  • Scott R; AbbVie Pharmaceuticals, Chicago, IL, USA.
  • Mahaffey KW; Stanford Center for Clinical Research (SCCR), Stanford University School of Medicine, Stanford, CA, USA.
  • Blaustein R; Merck Research Laboratories, Merck & Co., Inc, Kenilworth, NJ, USA.
  • Edelberg JM; Sanofi US, Bridgewater, NJ, USA.
  • Lefkowitz MP; Novartis Pharmaceuticals, East Hanover, NJ, USA.
  • Solomon SD; Harvard Medical School, Boston, MA, USA.
  • Fox JC; MyoKardia, Inc, South San Francisco, CA, USA.
  • Healy KE; University of California, Berkeley, Berkeley, CA, USA.
  • Khakoo AY; Amgen, Inc, Thousand Oaks, CA, USA.
  • Losordo DW; Caladrius Biosciences, New York, NY, USA.
  • Malik FI; Cytokinetics Inc, South San Francisco, CA, USA.
  • Monia BP; Ionis Pharmaceuticals, Carlsbad, CA, USA.
  • Montgomery RL; miRagen Therapeutics, Inc, Boulder, CO, USA.
  • Riesmeyer J; Eli Lilly, Inc, Indianapolis, IN, USA.
  • Schwartz GG; University of Colorado School of Medicine, Denver, CO, USA.
  • Zelenkofske SL; AstraZeneca Inc, Allentown, PA, USA.
  • Wu JC; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Wasserman SM; Amgen, Inc, Thousand Oaks, CA, USA.
  • Roe MT; Duke Clinical Research Institute, Duke University School of Medicine, 2400 Pratt Street, Duke Medicine, Durham, NC, 27705, USA.
Cardiovasc Drugs Ther ; 31(4): 445-458, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28735360
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Cardiovasculares / Doenças Cardiovasculares / Desenho de Fármacos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Cardiovasculares / Doenças Cardiovasculares / Desenho de Fármacos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article